Svai Sanford
Equibles does not estimate personal net worth.
About Svai Sanford
Earlier roles on record: CFO at Rani Therapeutics Holdings, Inc. (RANI) until May 15, 2026. Rani Therapeutics Holdings, Inc. reported in an 8-K filed May 15, 2026 that Svai Sanford resigned as Chief Financial Officer. The proxy statement of Rani Therapeutics Holdings, Inc. reports total compensation of $946,404 for Svai Sanford in fiscal 2025, including a base salary of $392,711. Disclosed compensation is on record for 5 fiscal years. Svai Sanford has spoken on 4 earnings calls across 1 company, most recently for Rani Therapeutics Holdings, Inc. on March 26, 2026. The companies whose calls Svai Sanford spoke on are classified in the Healthcare sector.
“On May 12, 2026, Svai Sanford, the Company's Chief Financial Officer, advised the Company that he will resign from his position following the appointment of his successor.”
Svai Sanford on recent calls
“As Talat has mentioned, earlier today we issued a press release and filed our Form 10-K with the SEC containing our financial results for the fourth quarter and full year 2025.”
“In addition to our financial results summarized in the press release that was issued earlier today, I will briefly share some key financial highlights on this call.”
“In addition to the financial results summarized in our press release that was issued earlier today, I will briefly share some key financial highlights on this call.”
“The press release we issued earlier today provides our financial results in detail, so I will only provide highlights on this call. Operating expenses for the fourth quarter and full year 2021 were $13.4 million and $54.3 million compared to $5.1 million and $17 million for the same period in 2020, respectively.”
Affiliation history
-
Start not stated–2026-05-15
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Financial Officer | $392,711 | $946,404 |
| 2024 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Financial Officer | $416,000 | $1,291,456 |
| 2023 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Financial Officer | $416,000 | $2,155,996 |
| 2022 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Financial Officer | $412,000 | $1,984,669 |
| 2021 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Financial Officer | $375,737 | $4,671,684 |